Cytori Therapeutics stock quote and CYTX charts. Latest stock price today and the US's most active stock market forums. Cytori Therapeutics Inc gained 1.76% in the last trading day ( Friday, 20th Dec 2019 ), rising from $2.27 to $2.31, and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 4.52% from a day low at $2.21 to a day high of Stock analysis for Plus Therapeutics Inc (CYTX) including stock price, stock chart, company news, key statistics, fundamentals and company profile. View detailed financial information, real-time news, videos, quotes and analysis on Cytori Therapeutics Inc. (NASDAQ:CYTX). Explore commentary on Cytori Therapeutics Inc. and hear what the experts at TheStreet are saying about CYTX. We are driven by the pursuit of safe and effective medical devices that improve the health and well-being of people. AUSTIN, Texas, July 29, 2019 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced that the Company has officially changed its name from “Cytori Therapeutics, Inc.” to “Plus Therapeutics, Inc.” and the ticker symbol for the Company’s common stock on the Nasdaq Capital Market will change from “CYTX” to “PSTV”. Get your free Cytori Therapeutics Inc stock live and up-to-date data - CYTX Quote, charts, rates, analysis, news & forecasts. Enter Now!
7/26/2019 · Real time Cytori Therapeutics (CYTX) stock price quote, stock graph, Cytori Therapeutics, and Omeros are among the health care stocks soaring this week.
3/8/2018 · Cytori Therapeutics (CYTX): FY EPS of -$0.65 misses by $0.39. Revenue of $6.41M (-43.7% Y/Y) misses by $8.51M. Press Release Get detailed financial information for the Cytori Therapeutics Inc (CYTX:) stock quote. View graphs, news, comments, and more. Welcome! Log into your account. your username. your password Investor Relations News Events Webcasts & Presentations Reports & Filings Stock Information Board Committees Corporate Governance Materials Meetings & Proxy Materials Information Request NEWS Cytori Will Become Plus Therapeutics, Inc. Plus Therapeutics Reflects A New Focus On Developing Innovative D 3/8/2018 · Over the past 90 days, analysts have adjusted their estimates higher for EPS and revenues. The popular rating by analysts on Cytori Therapeutics stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days. Conference Call. Don't be surprised to see the stock move on comments made during its conference call. Cytori Therapeutics, Inc, San Diego. 1.7K likes. Cytori is developing and commercializing cell therapies and nanomedicines for significant unmet medical
Get breaking news and analysis on Plus Therapeutics, Inc. (PSTV) stock, price quote and chart, trading and investing tools.
Welcome! Log into your account. your username. your password Investor Relations News Events Webcasts & Presentations Reports & Filings Stock Information Board Committees Corporate Governance Materials Meetings & Proxy Materials Information Request NEWS Cytori Will Become Plus Therapeutics, Inc. Plus Therapeutics Reflects A New Focus On Developing Innovative D